In today's world , People are affected by Factal Cervical Cancer
which is increased mostly in poor countries due to high price of cancer vaccine while compared to rich countries. It estimated 2,75,000 womens are killed in poor countries in a year. The pharmaceutical companies provided low price on their new products of decade ago with AIDS drugs.
According to Dr.Paul D.Blumenthal, a professor of Stanford University School of Medicine who point out cervical cancer in poor countries , said Mazel tov. The lower price starts from $4.50 for Mack's Gardasil vaccine and $4.60 for Glaxo Smith Kline's cervarix was created in 1999 to deliver more vaccine to the world's poor. Dr. Seth Bakley the alliance Chief executive said that by 2020, nearly 30 million girls in 40 countries get the vaccine at the less price.
In United States, the vaccine cost about $130 a dose. But in Latin
America countries get has a bulk rate of $ 13 paid by the Pan America Health Organisation. Latin America consists a mix of poor and middle-class people. The vaccine protect against from HPV, 70 percent of cervical cancer.
Glaxo reported on Wednesday that its manufacturing costs, and it remains in first places on the Access to Medicine index, introduced in 2008 measures by pharmaceutical companies sponser their goods to the poor.
Dr. Berkley , published the new prices for rival vaccine makes from lower cost countries like India and china. Other Companies, like Serum Institute of India the World's largest vaccine maker developing Papillomavirus vaccine.
He also said that the price are lower for the pentavalent vaccine, protect against from diphtheria, tetanus, cough, hepatitis B and Haemophilus influenza . In wealthy countries it cost shows $30 and alliance started getting at $3.50 and now it is getting to down $1.19,he said.
which is increased mostly in poor countries due to high price of cancer vaccine while compared to rich countries. It estimated 2,75,000 womens are killed in poor countries in a year. The pharmaceutical companies provided low price on their new products of decade ago with AIDS drugs.
According to Dr.Paul D.Blumenthal, a professor of Stanford University School of Medicine who point out cervical cancer in poor countries , said Mazel tov. The lower price starts from $4.50 for Mack's Gardasil vaccine and $4.60 for Glaxo Smith Kline's cervarix was created in 1999 to deliver more vaccine to the world's poor. Dr. Seth Bakley the alliance Chief executive said that by 2020, nearly 30 million girls in 40 countries get the vaccine at the less price.
In United States, the vaccine cost about $130 a dose. But in Latin
America countries get has a bulk rate of $ 13 paid by the Pan America Health Organisation. Latin America consists a mix of poor and middle-class people. The vaccine protect against from HPV, 70 percent of cervical cancer.
Glaxo reported on Wednesday that its manufacturing costs, and it remains in first places on the Access to Medicine index, introduced in 2008 measures by pharmaceutical companies sponser their goods to the poor.
Dr. Berkley , published the new prices for rival vaccine makes from lower cost countries like India and china. Other Companies, like Serum Institute of India the World's largest vaccine maker developing Papillomavirus vaccine.
He also said that the price are lower for the pentavalent vaccine, protect against from diphtheria, tetanus, cough, hepatitis B and Haemophilus influenza . In wealthy countries it cost shows $30 and alliance started getting at $3.50 and now it is getting to down $1.19,he said.